Autek China Inc.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Opcom Technology Co., Ltd. (referred to as "Opcom") is a high-tech enterprise specializing in eye health and myopia prevention and control technology and services. It was founded by Dr. Tao Yuequn, a Ph.D. in the United States in 2000, with a registered capital of 607 million yuan. Its headquarters are located in Hefei High tech Development Zone, covering an area of 30 acres and a building area of 44000 square meters. The company currently has over 280 subsidiaries and a total of over 1900 employees (including subsidiaries). In 2020, the total operating revenue was approximately 871 million, net profit was approximately 444 million, total assets were approximately 2.213 billion, net assets attributable to the parent company exceeded 1.752 billion, and taxes were approximately 127 million. The company was listed on the ChiNext board of the Shenzhen Stock Exchange in January 2017, with a current market value of over 55 billion yuan. It is the first domestic optometry technology enterprise to go public, and ranked eighth among Chinese medical device (including IVD) enterprises in 2020. OpScope's business includes two major segments: ophthalmology, optometry medical devices (products), and medical services. In terms of products, the current main products are hard contact lenses (contact lenses) such as corneal shaping lenses, as well as supporting care products. It is currently a research and production enterprise for hard contact lenses that is listed in China and also a large-scale research and production enterprise for corneal shaping lenses worldwide. Corneal shaping lenses are a special hard contact lens used to correct myopia. Wearing them while sleeping and taking them off during the day not only maintains clear daytime naked eye vision, but also slows down the deepening of myopia. They were included in the "Myopia Prevention and Control Guidelines" released by the National Health Commission in June 2018 and have been recognized by ophthalmologists and users. The company's products have the characteristics of intelligence and personalization, and have entered over 1100 well-known medical institutions in 30 provinces and cities except for Tibet in China, With a cumulative user base of over 1 million, DreamVision and Dream David have become well-known brands in this category of products. Wan Lijun, Chairman of the All China Federation of Overseas Chinese, and Jiao Hong, Director of the National Drug Administration, have come to the company for research and guidance. In addition to rigid contact lens products, the company is expanding its product and technology scope through independent research and development, commissioned development, cooperative development, investment and mergers and acquisitions, and has invested in medical device companies such as Guangzhou TV Bo, Guangzhou Juzhong, Hangzhou Mule, Anhui Boao, Anhui Ouwu, Shenzhen Kangkang, Hefei Kefei, Guangdong Shiming, Shenzhen Smart Eye, Hefei Oushidi, Hefei Ouzi, and Hefei Aitong, And with the support of the High tech Zone and the Provincial Overseas Chinese Affairs Office, a "Medical Device Innovation Base" has been established to incubate new products by providing trial production platforms, clinical trials and registration application guidance, funding and sales channel support, and reserve the momentum for subsequent development. In terms of medical and optometry technology services, the company has built ophthalmic hospitals in Hefei, Ma'anshan, Bengbu, Xuancheng, Lu'an, Guangde, and other ophthalmic hospitals in Ningguo and Langxi are under construction. At the same time, the company has over 200 ophthalmic outpatient departments, clinics, optometry centers, community eye health centers, etc. in Anhui, Jiangsu, Hubei, and other places. The company is increasing and accelerating its investment layout in the field of medical services, and plans to form a nationwide network of eye health and myopia prevention and control services. |
| Headquarter | Hefei |
| Establish Date | 10/26/2000 |
| Listed Code | 300595.SZ |
| Listed Date | 1/17/2017 |
| Chairman | Tao Yuequn. |
| CEO | Tao Yuequn. |
| Website | www.orthok.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
